
David Pirlot
Examiner (ID: 12288)
| Most Active Art Unit | 3202 |
| Art Unit(s) | 2833, 3202 |
| Total Applications | 1812 |
| Issued Applications | 1572 |
| Pending Applications | 21 |
| Abandoned Applications | 219 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19265291
[patent_doc_number] => 20240208990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/555213
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555213
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555213 | SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME | Apr 3, 2022 | Pending |
Array
(
[id] => 19187759
[patent_doc_number] => 20240166672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME
[patent_app_type] => utility
[patent_app_number] => 18/284202
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284202
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/284202 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | Mar 23, 2022 | Pending |
Array
(
[id] => 19105759
[patent_doc_number] => 11958840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Compounds, compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/702718
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22250
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702718
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/702718 | Compounds, compositions and methods | Mar 22, 2022 | Issued |
Array
(
[id] => 19299865
[patent_doc_number] => 20240228434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => PRODRUGS OF KV7 CHANNEL OPENERS
[patent_app_type] => utility
[patent_app_number] => 18/282940
[patent_app_country] => US
[patent_app_date] => 2022-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282940
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282940 | PRODRUGS OF KV7 CHANNEL OPENERS | Mar 19, 2022 | Pending |
Array
(
[id] => 19265197
[patent_doc_number] => 20240208896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => PRODRUGS OF KV7 CHANNEL OPENERS
[patent_app_type] => utility
[patent_app_number] => 18/282943
[patent_app_country] => US
[patent_app_date] => 2022-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282943
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282943 | PRODRUGS OF KV7 CHANNEL OPENERS | Mar 19, 2022 | Pending |
Array
(
[id] => 19432396
[patent_doc_number] => 20240300894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => PRODRUGS OF KV7 CHANNEL OPENERS
[patent_app_type] => utility
[patent_app_number] => 18/282934
[patent_app_country] => US
[patent_app_date] => 2022-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282934
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282934 | PRODRUGS OF KV7 CHANNEL OPENERS | Mar 19, 2022 | Pending |
Array
(
[id] => 17896957
[patent_doc_number] => 20220306619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => PRO DRUGS OF PDE10 COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/695125
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695125 | Pro drugs of PDE10 compounds | Mar 14, 2022 | Issued |
Array
(
[id] => 19142103
[patent_doc_number] => 20240140927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => 3-HYDROXYADIPIC ACID 3,6-LACTONE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/280557
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280557 | 3-HYDROXYADIPIC ACID 3,6-LACTONE COMPOSITION | Mar 10, 2022 | Pending |
Array
(
[id] => 17990157
[patent_doc_number] => 20220356194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => PROCESS FOR PREPARING BENZOTHIOPHEN-2YL BORONATE
[patent_app_type] => utility
[patent_app_number] => 17/691858
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691858
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691858 | PROCESS FOR PREPARING BENZOTHIOPHEN-2YL BORONATE | Mar 9, 2022 | Abandoned |
Array
(
[id] => 19233626
[patent_doc_number] => 20240190818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => NOVEL BIOACTIVE SUBSTANCE EXHIBITING ANTIMALARIAL ACTIVITY, AND USE FOR SAME
[patent_app_type] => utility
[patent_app_number] => 18/278325
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278325
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278325 | NOVEL BIOACTIVE SUBSTANCE EXHIBITING ANTIMALARIAL ACTIVITY, AND USE FOR SAME | Mar 2, 2022 | Pending |
Array
(
[id] => 18582833
[patent_doc_number] => 20230265088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => The Method of the Preparation of Fused Multicyclic Compounds
[patent_app_type] => utility
[patent_app_number] => 17/651769
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651769 | Method of the preparation of fused multicyclic compounds | Feb 17, 2022 | Issued |
Array
(
[id] => 19202739
[patent_doc_number] => 20240174638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => HETEROARYL DERIVATIVES AS APELIN RECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/278656
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278656 | HETEROARYL DERIVATIVES AS APELIN RECEPTOR AGONISTS | Feb 14, 2022 | Pending |
Array
(
[id] => 17641873
[patent_doc_number] => 20220169611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 17/672660
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 144370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672660
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672660 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | Feb 14, 2022 | Abandoned |
Array
(
[id] => 19556358
[patent_doc_number] => 20240368150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/546087
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 98461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546087
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546087 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | Feb 9, 2022 | Pending |
Array
(
[id] => 17953450
[patent_doc_number] => 11479541
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-10-25
[patent_title] => Acid addition salts, compositions, and methods of treating thereof
[patent_app_type] => utility
[patent_app_number] => 17/588847
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5372
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588847 | Acid addition salts, compositions, and methods of treating thereof | Jan 30, 2022 | Issued |
Array
(
[id] => 19187697
[patent_doc_number] => 20240166610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/263702
[patent_app_country] => US
[patent_app_date] => 2022-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263702
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263702 | SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES | Jan 28, 2022 | Pending |
Array
(
[id] => 19127129
[patent_doc_number] => 20240132482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => BENZO SEVEN-MEMBERED RING BIFUNCTIONAL COMPOUND AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/274674
[patent_app_country] => US
[patent_app_date] => 2022-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274674
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274674 | BENZO SEVEN-MEMBERED RING BIFUNCTIONAL COMPOUND AND APPLICATION THEREOF | Jan 28, 2022 | Pending |
Array
(
[id] => 19127105
[patent_doc_number] => 20240132458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => NLRP3 INFLAMMASOME SMALL-MOLECULE INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/275470
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275470
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275470 | NLRP3 INFLAMMASOME SMALL-MOLECULE INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE | Jan 27, 2022 | Pending |
Array
(
[id] => 19464063
[patent_doc_number] => 20240317732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13
[patent_app_type] => utility
[patent_app_number] => 18/262941
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262941 | A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13 | Jan 27, 2022 | Pending |
Array
(
[id] => 17611476
[patent_doc_number] => 20220153755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => NMDA RECEPTOR MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/585849
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585849
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585849 | NMDA receptor modulators and uses thereof | Jan 26, 2022 | Issued |